Elutia, Inc. (ELUT)
1.15
-0.02
(-1.71%)
USD |
NASDAQ |
Apr 17, 16:00
1.17
+0.02
(+1.74%)
After-Hours: 20:00
Elutia EPS Diluted (Quarterly) : -0.1283 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Abbott Laboratories | 0.6165 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1428 |
| Plus Therapeutics, Inc. | -1.03 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.51M |
| Revenue (Quarterly) | 3.271M |
| Total Expenses (Quarterly) | 9.781M |
| Enterprise Value | 24.02M |
| Gross Profit Margin (Quarterly) | 58.51% |
| Profit Margin (Quarterly) | -199.0% |
| Earnings Yield | -68.50% |
| Normalized Earnings Yield | -73.32 |